Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (701-710 of 1,253) with videos related to

Pageof 126
Sort By:
European Heart Journal|December 3, 2009
Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarctionMichael C Tjandrawidjaja, Yuling Fu, Cynthia M Westerhout, et al.
Journal of Thrombosis and Thrombolysis|June 5, 2013
Warfarin use and long-term outcomes in patients with acute myocardial infarction and atrial fibrillationJames A Nelson, John P Vavalle, Christopher H May, et al.
The American Journal of Cardiology|December 26, 2007
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromesSunil V Rao, Karen Chiswell, Jie-Lena Sun, et al.
American Heart Journal|December 15, 2010
Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): a randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes initially treated with fondaparinuxPhilippe Gabriel Steg, Shamir Mehta, Sanjit Jolly, et al.
JAMA|May 24, 1995
Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesF Van de Werf, E J Topol, K L Lee, et al.
Critical Care Medicine|December 24, 2009
Evolution of the coronary care unit: clinical characteristics and temporal trends in healthcare delivery and outcomesJason N Katz, Bimal R Shah, Elizabeth M Volz, et al.
The American Journal of Cardiology|January 15, 1993
Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observationsM W Krucoff, M A Croll, J E Pope, et al.
Heart (British Cardiac Society)|November 1, 2016
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillationM Cecilia Bahit, Renato D Lopes, Daniel M Wojdyla, et al.
JAMA Cardiology|July 21, 2016
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical TrialZiad Hijazi, Stefan H Hohnloser, Ulrika Andersson, et al.
Journal of Internal Medicine|May 1, 2020
Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trialH Røsjø, Z Hijazi, T Omland, et al.
Pageof 126

Showing results (701-710 of 1,253) with videos related to

Sort By:
Pageof 126
European Heart Journal|December 3, 2009
Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarctionMichael C Tjandrawidjaja, Yuling Fu, Cynthia M Westerhout, et al.
Journal of Thrombosis and Thrombolysis|June 5, 2013
Warfarin use and long-term outcomes in patients with acute myocardial infarction and atrial fibrillationJames A Nelson, John P Vavalle, Christopher H May, et al.
The American Journal of Cardiology|December 26, 2007
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromesSunil V Rao, Karen Chiswell, Jie-Lena Sun, et al.
American Heart Journal|December 15, 2010
Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): a randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes initially treated with fondaparinuxPhilippe Gabriel Steg, Shamir Mehta, Sanjit Jolly, et al.
JAMA|May 24, 1995
Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesF Van de Werf, E J Topol, K L Lee, et al.
Critical Care Medicine|December 24, 2009
Evolution of the coronary care unit: clinical characteristics and temporal trends in healthcare delivery and outcomesJason N Katz, Bimal R Shah, Elizabeth M Volz, et al.
The American Journal of Cardiology|January 15, 1993
Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observationsM W Krucoff, M A Croll, J E Pope, et al.
Heart (British Cardiac Society)|November 1, 2016
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillationM Cecilia Bahit, Renato D Lopes, Daniel M Wojdyla, et al.
JAMA Cardiology|July 21, 2016
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical TrialZiad Hijazi, Stefan H Hohnloser, Ulrika Andersson, et al.
Journal of Internal Medicine|May 1, 2020
Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trialH Røsjø, Z Hijazi, T Omland, et al.
Pageof 126